Effects of Aripiprazole on Olanzapine Population Pharmacokinetics and Initial Dosage Optimization in Schizophrenia Patients
Cun Zhang,Lei Jiang,Ke Hu,Liang Chen,Yi-Jia Zhang,Hao-Zhe Shi,Su-Mei He,Xiao Chen,Dong-Dong Wang
DOI: https://doi.org/10.2147/ndt.s455183
IF: 2.989
2024-03-05
Neuropsychiatric Disease and Treatment
Abstract:Cun Zhang, 1, &ast Lei Jiang, 2, 3, &ast Ke Hu, 2, &ast Liang Chen, 2 Yi-Jia Zhang, 2 Hao-Zhe Shi, 2 Su-Mei He, 4 Xiao Chen, 5 Dong-Dong Wang 2 1 Department of Pharmacy, Xuzhou Oriental Hospital Affiliated to Xuzhou Medical University, Xuzhou, Jiangsu, 221004, People's Republic of China; 2 Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy & School of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, People's Republic of China; 3 Department of Pharmacy, Taixing People's Hospital, Taixing, Jiangsu, 225400, People's Republic of China; 4 Department of Pharmacy, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, Jiangsu, 215153, People's Republic of China; 5 School of Nursing, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, People's Republic of China &astThese authors contributed equally to this work Correspondence: Su-Mei He, Department of Pharmacy, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, No. 1 Lijiang Road, Suzhou, Jiangsu, 215153, People's Republic of China, Email Dong-Dong Wang, Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy & School of Pharmacy, Xuzhou Medical University, No. 209 Tongshan Road, Xuzhou, Jiangsu, 221004, People's Republic of China, Email Objective: Olanzapine has already been used to treat schizophrenia patients; however, the initial dosage recommendation when multiple drugs are used in combination, remains unclear. The purpose of this study was to explore the drug–drug interaction (DDI) of multiple drugs combined with olanzapine and to recommend the optimal administration of olanzapine in schizophrenia patients. Methods: In this study, we obtained olanzapine concentrations from therapeutic drug monitoring (TDM) database. In addition, related medical information, such as physiological, biochemical indexes, and concomitant drugs was acquired using medical log. Sixty-five schizophrenia patients were enrollmented for analysis using population pharmacokinetic model by means of nonlinear mixed effect (NONMEM). Results: Weight and combined use of aripiprazole significantly affected olanzapine clearance. Without aripiprazole, for once-daily olanzapine administration dosages, 0.6, 0.5 mg/kg/day were recommended for 40– 70, and 70– 100 kg schizophrenia patients, respectively; for twice-daily olanzapine administration dosages, 0.6, 0.5 mg/kg/day were recommended for 40– 60, and 60– 100 kg schizophrenia patients, respectively. With aripiprazole, for once-daily olanzapine administration dosages, 0.4, 0.3 mg/kg/day were recommended for 40– 53, and 53– 100 kg schizophrenia patients, respectively; for twice-daily olanzapine administration dosages, 0.4 mg/kg/day was recommended for 40– 100 kg schizophrenia patients, respectively. Conclusion: Aripiprazole significantly affected olanzapine clearance, and when schizophrenia patients use aripiprazole, the olanzapine dosages need adjust. Meanwhile, we firstly recommended the optimal initial dosages of olanzapine in schizophrenia patients. Keywords: aripiprazole, olanzapine, population pharmacokinetics, initial dosage optimization, schizophrenia patients Schizophrenia affects about 1% of the global population, which is a debilitating disease that deserves the world's attention, 1–3 whose characteristics are manifold but typically include any or all of changes in behaviour, thought, perception, and cognition. 2 The etiologies of schizophrenia are complex, and the environment also plays an important role. 2,4–6 The origin of schizophrenia may come from utero: obstetric complications such as bleeding, asphyxia, low birth weight, gestational diabetes, and emergent caesarean section have been connected with the progression of schizophrenia. 7 In addition, social isolation, childhood trauma, urban dwelling, and ethnicity may also contribute. 2 Drugs are often the foundation of effective treatment and are the cornerstone of schizophrenia treatment. The most common prescription drugs are antipsychotics, which control symptoms by affecting dopamine. 8 The goal of drug therapy is to effectively manage symptoms at the optimized dosage possible. 9 First-generation antipsychotics are typical or traditional antipsychotics, such as chlorpromazine, haloperidol, perphenazine, et al, but may cause elevated prolactin levels, affecting libido, mood, menstrual cycles, and breast tissue in both men and women. 10 Newer antipsychotics are known as second-generation or atypical antipsychotics, su -Abstract Truncated-
psychiatry,clinical neurology